Literature DB >> 27392111

The safety of chronic antithrombotic therapy in patients with factor XI deficiency.

John Chapin1, Kelsey Klute1, Paul Christos2, Maria DeSancho1.   

Abstract

Entities:  

Keywords:  anticoagulation; bleeding disorders; factor XI

Mesh：

Substances：

Year:  2016        PMID： 27392111     DOI： 10.1111/bjh.14227

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Successful perioperative management in a patient with factor XI deficiency.

Authors:  Margaret L McCarthy; Sarah M Ordway; Ryan M Jones; Jeremy G Perkins
Journal:  BMJ Case Rep       Date:  2018-02-21

2.  Hemophilia C: A Case Report With Updates on Diagnosis and Management of a Rare Bleeding Disorder.

Authors:  Thejus Jayakrishnan; Deep Shah; Prerna Mewawalla
Journal:  J Hematol (Brossard)       Date:  2019-09-30

3.  Anticoagulant therapy in patients with congenital FXI deficiency.

Authors:  Carlos Bravo-Pérez; María Jose Serna; Julio Esteban; Eugenia Fernandez-Mellid; Emilia Fontanes-Trabazo; Alvaro Lorenzo; Michael Calviño-Suárez; Antonia Miñano; José Padilla; Vanessa Roldán; Vicente Vicente; Javier Corral; María Eugenia de la Morena-Barrio
Journal:  Blood Adv       Date:  2021-10-26

4.  Milvexian, an orally bioavailable, small-molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits.

Authors:  Pancras C Wong; Earl J Crain; Jeffrey M Bozarth; Yiming Wu; Andrew K Dilger; Ruth R Wexler; William R Ewing; David Gordon; Joseph M Luettgen
Journal:  J Thromb Haemost       Date:  2021-11-24       Impact factor: 16.036
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.